Dr. Sonya Reid introduces the program by outlining the objectives of the discussion, which focus on the expanding role of genomic testing in the management of early-stage HR-positive, HER2-negative breast cancer.
Sonya Reid, MD, MPH
Advertisement
Articles by Sonya Reid, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
T-DXd Wins EU Approval for Previously Treated, HER2+ Metastatic Solid Tumors
2
Elisrasib Yields Durable Responses in Pretreated KRAS G12C–Mutant NSCLC Regardless of Prior G12C Inhibitor Use
3
FDA Issues CRL to PET Diagnostic Imaging Kit for Gallium-68 Edotreotide in SSTR+ NETs
4
Pembrolizumab Biosimilar Meets Primary Phase 1 and Phase 3 End Points in NSCLC
5